Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and De... Read more
This company has no offices yet
Sézane
15 followers
DHR Global
9 followers
Amazon KDP Publishing
8 followers
LG Energy Solution Vertech, Inc.
6 followers
PURPLE
5 followers
Behance
2 followers
DLB Associates
2 followers
Spardha
2 followers
Bridge Over Troubled Waters
2 followers
Aspen Publishing
2 followers
Mahindra Group
1237 followers
Ethos
1 follower